Covered recipient · General Payments record
KELLY SUE PRINDLE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,167.31
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $498.75 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $121.46 | 6 |
| Abbott Laboratories | $66.53 | 3 |
| Novo Nordisk AS | $64.07 | 4 |
| DEXCOM, INC. | $57.42 | 3 |
| GlaxoSmithKline, LLC. | $45.45 | 3 |
| Lilly USA, LLC | $42.53 | 2 |
| PFIZER INC. | $33.57 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.79 | 1 |
| Amgen Inc. | $18.84 | 1 |
| Exact Sciences Corporation | $15.71 | 1 |
| Acerta Pharma LLC | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.19 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124813443 | CMS |
| Abbott Laboratories | $19.91 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124813445 | CMS |
| Abbott Laboratories | $23.43 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124813447 | CMS |
| ABBVIE INC. | $14.74 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315520 | CMS |
| ABBVIE INC. | $20.60 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315524 | CMS |
| ABBVIE INC. | $27.33 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315529 | CMS |
| ABBVIE INC. | $24.08 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315533 | CMS |
| ABBVIE INC. | $16.39 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315536 | CMS |
| ABBVIE INC. | $18.32 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105315541 | CMS |
| Amgen Inc. | $18.84 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117357498 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.38 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105487071 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.79 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117850957 | CMS |
| Dexcom, Inc. | $14.59 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313733 | CMS |
| Dexcom, Inc. | $20.18 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313735 | CMS |
| Dexcom, Inc. | $22.65 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313737 | CMS |
| Exact Sciences Corporation | $15.71 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114841511 | CMS |
| GlaxoSmithKline, LLC. | $15.74 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116283105 | CMS |
| GlaxoSmithKline, LLC. | $13.42 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116606958 | CMS |
| GlaxoSmithKline, LLC. | $16.29 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115922073 | CMS |
| Lilly USA, LLC | $20.92 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096990 | CMS |
| Lilly USA, LLC | $21.61 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135096992 | CMS |
| Novo Nordisk Inc | $14.33 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097276323 | CMS |
| Novo Nordisk Inc | $13.34 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097211289 | CMS |
| Novo Nordisk Inc | $14.61 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096893757 | CMS |
| Novo Nordisk Inc | $21.79 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096698193 | CMS |
| PFIZER INC. | $18.22 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131837606 | CMS |
| PFIZER INC. | $15.35 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132104119 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.